BackGalmed Pharmaceuticals Overview

Galmed Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GLMD.

Quarterly EBIT

-$3.04M
↑ 5.2% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$8.51M
↓ 8.5% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin